Cargando…

The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma

Long noncoding RNAs (lncRNAs) are closely associated with a variety of tumors, including stomach adenocarcinoma (STAD). However, the role of 5-methylcytosine- (m5C-) related lncRNAs in STAD is still uncertain. This study investigated the value of m5C-related lncRNAs in prognostic evaluation and immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Chenxi, Zhu, Xinying, Kong, Fanting, Zhang, Xiaochong, Chai, Xiukun, Zou, Chunyan, Zhao, Dongqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197623/ https://www.ncbi.nlm.nih.gov/pubmed/35711526 http://dx.doi.org/10.1155/2022/2747799

Ejemplares similares

Effect of Probiotic-Assisted Eradication of cagA+/vacA s1m1 Helicobacter pylori on Intestinal Flora
por: He, Chenxi, et al.
Publicado: (2022)

Retracted: The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma
por: International, BioMed Research
Publicado: (2023)

Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma
por: Han, Chen, et al.
Publicado: (2021)

Construction of stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance
por: Lu, Lina, et al.
Publicado: (2023)

Prognostic value and immune landscapes of immunogenic cell death-associated lncRNAs in lung adenocarcinoma
por: Shu, Kexin, et al.
Publicado: (2023)

Immune Infiltration and Clinical Outcome of Super-Enhancer-Associated lncRNAs in Stomach Adenocarcinoma
por: Peng, Li, et al.
Publicado: (2022)

The role of LncRNAs in tumor immunotherapy
por: Pan, Xuan, et al.
Publicado: (2023)

Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma
por: Zhu, Xinying, et al.
Publicado: (2020)

Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA‐lncRNA co‐expression network analysis
por: Li, Qun, et al.
Publicado: (2020)

Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma
por: Xu, Yue, et al.
Publicado: (2022)

The value of metabolic LncRNAs in predicting prognosis and immunotherapy efficacy of gastric cancer
por: Du, Peizhun, et al.
Publicado: (2023)

Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma
por: Mo, Jiantao, et al.
Publicado: (2022)

Potential Prognostic Value of a Seven m6A-Related LncRNAs Signature and the Correlative Immune Infiltration in Colon Adenocarcinoma
por: Chai, Xiu-kun, et al.
Publicado: (2021)

Ferroptosis-Related lncRNAs Act as Novel Prognostic Biomarkers in the Gastric Adenocarcinoma Microenvironment, Immunotherapy, and Chemotherapy
por: Zheng, Yushi, et al.
Publicado: (2023)

A prognostic and immunotherapy effectiveness model for pancreatic adenocarcinoma based on cuproptosis-related lncRNAs signature
por: Zhang, Ning, et al.
Publicado: (2023)

The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma
por: Zhou, Wencheng, et al.
Publicado: (2022)

Potential Value of Circular RNA circTBC1D4 in Gastrointestinal Stromal Tumors
por: Chunyan-Zou,, et al.
Publicado: (2022)

Prognostic Value of Genomic Instability of m(6)A-Related lncRNAs in Lung Adenocarcinoma
por: Li, Rui, et al.
Publicado: (2022)

Prognostic value and immune landscapes of immunogenic cell death-related lncRNAs in hepatocellular carcinoma
por: Chen, Wanying, et al.
Publicado: (2023)

Identification of Tumor Microenvironment-Related Prognostic lncRNAs in Lung Adenocarcinoma
por: Yuan, Ligong, et al.
Publicado: (2021)

Identification of cuproptosis‐related lncRNAs for prognosis and immunotherapy in glioma
por: Wang, Lin, et al.
Publicado: (2022)

Tumor necrosis factor-related lncRNAs predict prognosis and immunotherapy response for patients with lung adenocarcinoma
por: Chen, Jin-Hua, et al.
Publicado: (2023)

A cuproptosis-related lncRNAs risk model to predict prognosis and guide immunotherapy for lung adenocarcinoma
por: Li, Qixuan, et al.
Publicado: (2023)

Decoding LncRNAs
por: Borkiewicz, Lidia, et al.
Publicado: (2021)

Values and Limitations of Targeting lncRNAs in Diabetic Nephropathy
por: Long, Jianyin, et al.
Publicado: (2018)

miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
por: Di Martino, Maria Teresa, et al.
Publicado: (2021)

Identification of novel key regulatory lncRNAs in gastric adenocarcinoma
por: Razavi, Houri, et al.
Publicado: (2022)

The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma
por: Melendez-Zajgla, Jorge, et al.
Publicado: (2021)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

A Seven Immune-Related lncRNAs Model to Increase the Predicted Value of Lung Adenocarcinoma
por: Li, Jian-Ping, et al.
Publicado: (2020)

Prognostic value of lncRNAs in lung carcinoma: a meta-analysis
por: Fan, Fan, et al.
Publicado: (2017)

Identification of immune-associated lncRNAs as a prognostic marker for lung adenocarcinoma
por: He, Chunming, et al.
Publicado: (2021)

LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy
por: Egranov, Sergey D., et al.
Publicado: (2020)

Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs
por: Wang, Guowei, et al.
Publicado: (2022)

Characterization of the immune related lncRNAs in bladder cancer to aid immunotherapy
por: Xiao, Ying, et al.
Publicado: (2022)

Functions and properties of nuclear lncRNAs—from systematically mapping the interactomes of lncRNAs
por: Guh, Chia-Yu, et al.
Publicado: (2020)

Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients
por: Li, Qinglin, et al.
Publicado: (2023)

LncRNAs and CircRNAs in cancer
por: Yin, Xin, et al.
Publicado: (2022)

Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy
por: Eptaminitaki, Giasemi C., et al.
Publicado: (2021)

LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma
por: Liu, Bing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0kfbia67n2apoaf1d6al5kcmf6